Abstract
14-OR: Autonomous Artificial Intelligence Diabetic Eye Exams Mitigates Disparities in Screening Completion for Youth
Diabetes (New York, N.Y.), Vol.73(Supplement_1)
06/14/2024
DOI: 10.2337/db24-14-OR
Abstract
Diabetic retinal disease (DRD) is a complication of diabetes mellitus that can lead to vision loss; early detection through screening and treatment can prevent this. Few individuals with diabetes meet recommended DRD screening guidelines, and racial/ethnic minority youth are even less likely to undergo recommended screening. We sought to determine if implementing point of care (POC) autonomous artificial intelligence (AI) screening could mitigate disparities in diabetic eye exam completion. In ACCESS2, a preregistered prospective pre-post study design, youth with type 1(T1D) and type 2 diabetes (T2D) meeting American Diabetes Association criteria for needing a diabetic eye exam underwent POC autonomous AI diabetic eye exams at routine diabetes clinic visits. Completion rates of diabetic eye exams were compared prior to and after implementation of autonomous AI. A total of 380 youth with T1D (71.1%) and T2D (28.9%) were enrolled, mean age 15.2y, 46.8% Non-Hispanic (NH) White, with mean duration of diabetes of 6.0y, and median hemoglobin A1c of 8.1%. A greater percentage of NH White participants reported any prior diabetic eye exam (81.6 v 62.0%, p<0.001) compared to non-white and Hispanic participants. Multivariable analysis demonstrated that the strongest predictor for prior eye exam was diabetes duration. After undergoing POC autonomous AI diabetic eye exams, completion rates were 98% among non-white and Hispanic participants, and 99% among white participants. Introducing autonomous AI at the point of care enhances the accessibility and completion rates of diabetic screening eye exams, and promotes health equity for minority youth with diabetes. Disclosure D. Patel: None. L.A. Bromberger: None. N. Parimi: None. E.A. Brown: None. A. Liu: None. H. Lehmann: None. M.D. Abràmoff: Board Member; Digital Diagnostics. Stock/Shareholder; Digital Diagnostics. Other Relationship; Digital Diagnostics. R.M. Wolf: Research Support; Dexcom, Inc., Boehringer-Ingelheim, Novo Nordisk. Funding National Eye Institute (R01EY033233-03)
Details
- Title: Subtitle
- 14-OR: Autonomous Artificial Intelligence Diabetic Eye Exams Mitigates Disparities in Screening Completion for Youth
- Creators
- DHRUVA PatelLEE A. BrombergerNEHA ParimiELIZABETH A. BrownALVIN LiuHAROLD LehmannMICHAEL D. AbràmoffRISA M. Wolf
- Resource Type
- Abstract
- Publication Details
- Diabetes (New York, N.Y.), Vol.73(Supplement_1)
- Publisher
- AMER DIABETES ASSOC
- DOI
- 10.2337/db24-14-OR
- ISSN
- 0012-1797
- eISSN
- 1939-327X
- Grant note
- National Eye Institute: R01EY033233-03
National Eye Institute (R01EY033233-03)
- Language
- English
- Date published
- 06/14/2024
- Academic Unit
- Electrical and Computer Engineering; Fraternal Order of Eagles Diabetes Research Center; Ophthalmology and Visual Sciences
- Record Identifier
- 9984648060302771
Metrics
1 Record Views